Jump to content
RemedySpot.com

LDN for autism-therapy?

Rate this topic


Guest guest

Recommended Posts

Guest guest

hi, I'm not making any claims as I have no personal experience, but this sounds

kind of promising!  Just sharing this group which my friend just sent me

Liora

---------- Forwarded message ----------

> From: Autism_LDN

Moderator <Autism_LDN-owner >

Autism_LDN-owner{at}  visit

<Autism_ldn/> to join 

>

>

>

Date: Sat, May 22, 2010 at 9:19 AM

> Subject: File - LDN for

Immunomodulation

>

>

>

>

>

>

LDN - LOW-DOSE NALTREXONE FOR IMMUNOMODULATION

>

>

>

>

Naltrexone is an FDA-approved drug used as an opiate antagonist for

>

treating

>

> opiate drug and alcohol addiction since the

1970's, available in generic

>

> form as well as ReVia in

50mg tablets. At regular dosing, usually 50mg a

>

> day, it

blocks the euphoric response to opiate drugs such as heroin or

>

>

morphine. I as well as many other DAN! doctors have tried Naltrexone

with

>

> our ASD children hoping to offset the " opioid "

effects of the large

> peptides

>

> in wheat, milk and

soy. I found it mostly ineffective and abandoned this

>

>

therapy long ago. Naltrexone has always been considered very safe and

has

>

> never been reported as being addicting.

>

>

>

>

Opioids are known to operate as cytokines, the principal communication

>

>

signalers of the immune system, creating immunomodulatory effects

through

>

> opioid receptors on immune cells. A popular

immune classification method is

>

> referred to as the

Th1/Th2 balance; Th1 cells promote cell-mediated

> immunity

>

>

while Th2 cells induce humoral immunity. The inability to respond

>

adequately

>

> with a Th1 response can result in chronic

infection and cancer; an

>

> overactive Th2 response can

contribute to allergies and various syndromes

>

> and play a

role in autoimmune disease, which most ASD children show on

>

>

immune testing.

>

>

>

> Bernard Bihari, MD, a

New York physician studying the immune responses in

>

> AIDs

patients, discovered that a very low dose of naltrexone in less than

>

>

one-tenth the usual dosage boosts the immune system and helps fight

>

diseases

>

> characterized by inadequate immune function.

Low-Dose Naltrexone (LDN)

> tends

>

> to normalize the

immune system by elevating the body's endorphin levels and

>

>

accomplishes its results with virtually no side effects or toxicity.

Since

>

> endorphins are an integral part of the immune

system, when a tiny dose of

>

> naltrexone is given between

9-12pm at night the body attempts to overcome

>

> the opioid

block and the endorphins rise, to stay elevated throughout the

>

>

next 18 hours.

>

>

>

> LDN had been studied in

ASD children using from 5-12.5mg daily or every

>

> other

day in the early 90s; researchers were looking for opioid antagonism.

>

>

Results were equivocal with non-compliance because of the bitterness of

the

>

> drug. Dr. Tyrus at Coastal Compounding agreed

to create a transdermal

>

> cream for my study; that way we

could adjust the dose easily (some of the

>

> smaller kids

did better with only 1-1/2mg), the bitter taste was no

> problem,

>

>

and it could be put on their bodies while they slept. The cream is put

into

>

> syringes, ? cc providing 3mg, with a month's supply

of the child dose (3mg)

>

> costing $19, the adult dose

(4.5mg) $30, plus shipping, no refrigeration

>

> required.

Dr. has offered to share this very effective formula with

>

>

any compounding pharmacist who wishes to call him, 912-354-5188.

>

>

>

>

I have completed an 8-week informal clinical study on 15 of my ASD

patients

>

> using 3mg of LDN transdermally between 9-12pm.

Several adults participated

>

> also, one with Crohn's

Disease and one with Chronic Fatigue Syndrome using

>

>

4.5mg nightly. Parents reported weekly; 8 of the 15 children had

positive

>

> responses, with five of these 8 having results

considered quite phenomenal

>

> according to their parents.

The primary positive responses have been in the

>

> area of

mood, cognition, language, and socialization. 5 of the children had

>

>

equivocal results and three children dropped out, one because of no

>

response

>

> after 4 weeks, the other two for personal

family reasons. Two very small

>

> children did better when

changed to 1-1/2mg dosing. No allergic reactions

>

> were

noted to the cream, with the primary negative side effect being

>

>

insomnia and earlier awakening when first taking it, usually lasting

3-5

>

> days. The two adults in the study, one with Crohn's

and the other with

>

> Chronic Fatigue Syndrome, have had

very positive responses; the Crohn's

>

> participant says

she has been in remission since starting LDN (almost 3

>

>

months now). All participants who completed my study have indicated they

>

>

wish to continue, and hundreds of other ASD kids have started this

>

>

non-toxic, non-invasive, inexpensive intervention by now.

>

>

>

>

All my study children were on well-controlled dietary restriction. I am

>

>

receiving reports from the e-lists I monitor of about 5% of other

children

>

> besides those in my study having side effects

such as irritability,

>

> agitation, and restlessness. Side

effects subside as soon as the drug is

>

> withdrawn. I am

querying these parents about gluten/casein/soy in diet, as

>

>

this could be withdrawal symptoms of opioid block. I suspect that

children

>

> on a strict GF/CF/SF diet may demonstrate the

positive immune modulation

>

> effect sooner than the child

who needs to go through opioid withdrawal

>

> first, but I

assume it is possible for the block to stimulate withdrawal

>

>

effects and also have the endorphin rush if parents want to stick out

the

>

> side effects.

>

>

>

> It may

be a while before a formal study can be conducted, so although I

>

>

assume the positive effects are due to up-regulation of the immune

system,

> I

>

> do not yet have studies to prove it. I

suspect we will get lots of informal

>

> clinical data long

before we can get a formal study conducted. I am hoping

>

>

this will be another weapon in our ever-expanding arsenal to help the

>

>

children get as immune-efficient as possible. I want to thank those who

>

>

participated in the study for being trusting enough to go along with me

in

>

> trying something new, and I thank Dr. Tyrus at

Coastal Compounding

> for

>

> helping devise a

successful form to use in our children. This list

> has

>

>

been started for reporting and discussion of this intervention.

Jaquelyn

>

> McCandless, M.D. 7-18-05

>

>

>

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...